This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Polyphor Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Manuella Schmitt-Billet
Introduction
Manuella Schmitt-Billet is a notable inventor based in Hagental-le-Bas, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of peptidomimetics. Her work focuses on creating compounds that can inhibit elastase, an enzyme linked to various diseases.
Latest Patents
Manuella holds a patent for "Beta-hairpin peptidomimetics as selective elastase inhibitors." This invention involves peptidomimetics of the general formula cyclo(-Xaa-Xaa-Thr-Xaa-Ser-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-), which exhibit elastase inhibitory properties, especially against human neutrophil elastase. These compounds can be utilized to prevent infections or diseases related to such infections in healthy individuals or to slow infections in infected patients. Furthermore, the compounds can be beneficial in treating conditions where elastase activity mediates cancer, immunological diseases, pulmonary diseases, cardiovascular diseases, neurodegenerative diseases, inflammation, or diseases related to inflammation. The manufacturing process of these peptidomimetics is based on a mixed solid- and solution-phase synthetic strategy.
Career Highlights
Manuella Schmitt-Billet is currently associated with Polyphor AG, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in therapeutic solutions.
Collaborations
Manuella has collaborated with notable colleagues, including Frank Otto Gombert and Daniel Obrecht. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.
Conclusion
Manuella Schmitt-Billet's contributions to the field of medicinal chemistry through her innovative patents and collaborations highlight her role as a leading inventor. Her work in developing selective elastase inhibitors showcases the potential for new therapeutic approaches to combat various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile